Research

Clinical research shows PEPID can be a key contributor to better education and clinical performance for both physicians and nurses.

Physicians Using PEPID on their Mobile Devices Improve Clinical Performance by 50%

A University of Toronto study shows that physicians using PEPID on mobile devices improved their clinical performance by 50 percent. The physicians who did not use PEPID showed no improvement. The researchers noted that doctors, who used books and other traditional references, took from 10 to 15 minutes to find answers to clinical questions – when they bothered to look them up at all. Those using PEPID software found their answers in an average of 19 seconds. The study concludes that physicians who use a handheld device to access medical information improve the speed and quality of their diagnoses (Lapinsky, et al).

A project at Duke University School of Nursing showed that adopting PEPID on mobile devices can make significant contributions to the development of leadership skills, enhanced learning, reinforcement of core knowledge and building student confidence. Students used PEPID's Student Nursing Care Plans for quick access to information on drugs, drug interactions and specific diseases; nursing considerations, procedures and protocols. Using PEPID, students better understood the patient situation and possible nursing interventions. The project also found that PDAs are especially useful in clinical settings, where other resources may not be readily available (White, et al).

PEPID's drug database scored highest on a combination of the features that mean the most to clinical practitioners including structured information on indications and dosing, side effects, drug interactions and 'special features' like medical calculators and treatment algorithms. The study, mobile device-based drug reference software as tools to improve traditional prescribing: Benchmark criteria and performance, Knollmann et al, was supported by the National Institute of Health and issued from the Division of Clinical Pharmacology and Center for Drug Development Sciences, Georgetown University Medical Center.